Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$554M |
| 2 |
Apple
AAPL
|
+$513M |
| 3 |
Illumina
ILMN
|
+$360M |
| 4 |
argenx
ARGX
|
+$304M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$482M |
| 2 |
Sherwin-Williams
SHW
|
+$314M |
| 3 |
AbbVie
ABBV
|
+$310M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$244M |
| 5 |
Atlassian
TEAM
|
+$233M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.85% |
| 2 | Healthcare | 19.69% |
| 3 | Industrials | 10.47% |
| 4 | Financials | 10.02% |
| 5 | Consumer Discretionary | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2576
Kiniksa Pharmaceuticals
KNSA
$6.08B
| $133K | ﹤0.01% |
+12,376
| New | +$163K |
|
2577
Hagerty
HGTY
$1.31B
| $132K | ﹤0.01% |
+15,071
| New | +$137K |
|
2578
Dyne Therapeutics
DYN
$4.96B
| $130K | ﹤0.01% |
+11,339
| New | +$147K |
|
|
BLUE
2579
DELISTED
bluebird bio
BLUE
| $130K | ﹤0.01% |
2,032
+935
| +85% | +$107K |
|
2580
SmartRent
SMRT
$274M
| $129K | ﹤0.01% |
50,516
+31,066
| +160% | +$83.3K |
|
2581
Douglas Elliman
DOUG
$185M
| $129K | ﹤0.01% |
43,397
+17,657
| +69% | +$70.4K |
|
2582
Cricut
CRCT
$1.25B
| $128K | ﹤0.01% |
+12,548
| New | +$121K |
|
|
HRT
2583
DELISTED
HireRight Holdings Corporation
HRT
| $127K | ﹤0.01% |
+11,972
| New | +$135K |
|
2584
Senseonics Holdings Inc
SENS
$412M
| $126K | ﹤0.01% |
9,005
+5,290
| +142% | +$106K |
|
2585
LivePerson
LPSN
$32.6M
| $126K | ﹤0.01% |
1,908
-175,254
| -99% | -$28.1M |
|
|
AMRS
2586
DELISTED
Amyris Inc.
AMRS
| $126K | ﹤0.01% |
93,106
+61,271
| +192% | +$87.5K |
|
|
MRSN
2587
DELISTED
Mersana Therapeutics
MRSN
| $126K | ﹤0.01% |
1,226
+772
| +170% | +$108K |
|
|
AMPS
2588
DELISTED
Altus Power
AMPS
| $126K | ﹤0.01% |
22,904
+12,198
| +114% | +$85.6K |
|
|
TPC
2589
Tutor Perini Cor
TPC
$5.13B
| $124K | ﹤0.01% |
+20,157
| New | +$162K |
|
2590
Ribbon Communications
RBBN
$356M
| $124K | ﹤0.01% |
36,181
+17,586
| +95% | +$64.3K |
|
2591
Erasca
ERAS
$6.37B
| $122K | ﹤0.01% |
+40,666
| New | +$148K |
|
|
PTRA
2592
DELISTED
Proterra Inc. Common Stock
PTRA
| $121K | ﹤0.01% |
80,029
+43,034
| +116% | +$162K |
|
2593
Atea Pharmaceuticals
AVIR
$400M
| $120K | ﹤0.01% |
35,909
+17,769
| +98% | +$72.1K |
|
|
NVTA
2594
DELISTED
Invitae Corporation
NVTA
| $119K | ﹤0.01% |
88,694
+54,375
| +158% | +$107K |
|
2595
Pulmonx
LUNG
$100M
| $119K | ﹤0.01% |
+10,672
| New | +$105K |
|
2596
1-800-Flowers.com
FLWS
$259M
| $117K | ﹤0.01% |
+10,205
| New | +$104K |
|
2597
NextDecade
NEXT
$1.8B
| $117K | ﹤0.01% |
23,543
+11,657
| +98% | +$67.7K |
|
2598
Funko
FNKO
$335M
| $117K | ﹤0.01% |
+12,431
| New | +$129K |
|
|
GPMT
2599
Granite Point Mortgage Trust
GPMT
$60.2M
| $116K | ﹤0.01% |
23,420
+12,219
| +109% | +$71.1K |
|
2600
Robinhood
HOOD
$84.4B
| $115K | ﹤0.01% |
11,896
+225
| +2% | +$2.15K |
|
Similar funds
Janus Henderson Group's Q1 2023 Portfolio in Review
As of Q1 2023, Janus Henderson Group held 2,845 positions worth $152B, up 8.3% from $140B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Janus Henderson Group's Q1 2023 filing shows 389 new, 1,670 increased, 578 reduced and 160 closed positions. Its largest new stake was GE HealthCare: 882,749 shares worth $72.4M. The largest sale was Meta Platforms (Facebook), an estimated $482M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 28% a quarter earlier, followed by Healthcare and Industrials.
- Janus Henderson Group's largest Q1 2023 buy was GE HealthCare: 882,749 shares worth $72.4M.
- Janus Henderson Group added most to Linde in Q1 2023, an estimated $554M increase.
- Janus Henderson Group's biggest Q1 2023 reduction was Meta Platforms (Facebook), cutting an estimated $482M.
- Janus Henderson Group fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $31.7M.
- Janus Henderson Group's ten largest holdings make up 24% of its $152B portfolio in Q1 2023.
- Janus Henderson Group opened 389 new positions and closed 160 in Q1 2023.
- Janus Henderson Group's portfolio value rose 8.3% quarter-over-quarter to $152B.
Based on Janus Henderson Group's 13F filing for Q1 2023, filed 15 May 2023.